Found 1005 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
ER+/HER2- Breast Cancer
People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
- 9 views
- 27 Jan, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
HER2-negative advanced breast cancer
People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
- 21 views
- 02 Aug, 2019
- 1 location
-
Phase 2 trial
-
Accepting pediatric ages
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer
- 378 views
- 23 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial (Alliance A011502)
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial (Alliance A011502)
- 560 views
- 03 Dec, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2/NEU NEGATIVE BREAST CANCER.
PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2
- 220 views
- 24 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
- 66 views
- 03 Dec, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
Advanced Breast Cancer with Visceral Metastases
People with advanced breast cancer are asked to participate in a research study being conducted by White Plains Hospital.
- 22 views
- 02 Aug, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Oncology
-
Currently Recruiting
HER2 Negative Advanced Breast Cancer
People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Queens Hospital Center.
- 27 views
- 28 Oct, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
CheckMate 7A8 - ER+/HER2- Breast Cancer
People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
- 4 views
- 23 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
Receptor 2 negative (HR+/HER2-) breast cancer – Astra Zeneca
People with breast cancer are asked to participate in a research study being conducted by Monter Cancer Center.
- 0 views
- 22 Jul, 2020
- 1 location